Sabrina Binti Haron

Chief Compliance Officer

Date of Appointment to Current Position
1 July 2023

44

F

Directorship in Other Public Companies and Other Listed Entities:

None

Family Relationship with Any Director and/or Major Shareholder:

None

Conflict of Interest or Potential Conflict of Interest, Including Interest in Any Competing Business with the Company or Its Subsidiaries:

None

List of Convictions for Offences within the Past 5 Years and Particulars of Any Public Sanction or Penalty Imposed by the Relevant Regulatory Bodies during the Financial Year:

None

Details of Any Interest in the Securities of the Company or Its Subsidiaries:

None

Academic/Professional Qualification/Membership(s):

  • Bachelor of Pharmacy (Hons), National University of Malaysia (UKM)
  • Executive Master in Business Administration, Universiti Teknologi MARA (UiTM)
  • Oxford Executive Leadership Programme, Saïd Business School, University of Oxford
  • Member of the Malaysian Pharmacists Society
  • Member of the Malaysian Affiliate of the International Society for Pharmaceutical Engineering 

Past Appointments/Experiences:

  • Houseman Pharmacist, General Hospital of Kuala Lumpur from 2004-2005
  • Regulatory Affairs Manager, 21st Century Products Sdn Bhd 2005 – Nov 2009
  • Regulatory Affairs Manager, Duopharma (M) Sdn Bhd from Dec 2009 to Jun 2014
  • Regulatory Affairs Senior Manager, Duopharma (M) Sdn Bhd Jul 2014 to Jun 2020 
  • Technical Compliance Senior Manager, Duopharma (M) Sdn Bhd from Jul 2020- March 2021
  • Technical Compliance General Manager, Duopharma (M) Sdn Bhd from April 2021-June 2023

Other Current Appointment(s):

  • Member of Duopharma Biotech’s Group Management Committee
  • Member of the Executive Council of the Malaysian Organisation of Pharmaceutical Industries (MOPI)
  • Member of the National Medicine Policy (DUNAS), Technical Committee of Quality, Safety & Efficacy Component. 
  • Member of Biosimilars Committee of International Generic and Biosimilar Medicines Association (IGBA)
  • Member of Malaysia Pharmacy Board Investigation Committee